These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38583808)

  • 81. Pathogenesis of simian varicella virus.
    Gray WL
    J Med Virol; 2003; 70 Suppl 1():S4-8. PubMed ID: 12627479
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
    Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    Elife; 2020 Oct; 9():. PubMed ID: 33112236
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The genomes of simian varicella virus and varicella zoster virus are colinear.
    Pumphrey CY; Gray WL
    Virus Res; 1992 Dec; 26(3):255-66. PubMed ID: 1337232
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight.
    Khan MI; Khan ZA; Baig MH; Ahmad I; Farouk AE; Song YG; Dong JJ
    PLoS One; 2020; 15(9):e0238344. PubMed ID: 32881907
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
    Chi X; Yan R; Zhang J; Zhang G; Zhang Y; Hao M; Zhang Z; Fan P; Dong Y; Yang Y; Chen Z; Guo Y; Zhang J; Li Y; Song X; Chen Y; Xia L; Fu L; Hou L; Xu J; Yu C; Li J; Zhou Q; Chen W
    Science; 2020 Aug; 369(6504):650-655. PubMed ID: 32571838
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses.
    Gussow AB; Auslander N; Faure G; Wolf YI; Zhang F; Koonin EV
    Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15193-15199. PubMed ID: 32522874
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
    Dieterle ME; Haslwanter D; Bortz RH; Wirchnianski AS; Lasso G; Vergnolle O; Abbasi SA; Fels JM; Laudermilch E; Florez C; Mengotto A; Kimmel D; Malonis RJ; Georgiev G; Quiroz J; Barnhill J; Pirofski LA; Daily JP; Dye JM; Lai JR; Herbert AS; Chandran K; Jangra RK
    Cell Host Microbe; 2020 Sep; 28(3):486-496.e6. PubMed ID: 32738193
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection.
    Carlos AJ; Ha DP; Yeh DW; Van Krieken R; Tseng CC; Zhang P; Gill P; Machida K; Lee AS
    J Biol Chem; 2021; 296():100759. PubMed ID: 33965375
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Characterization of the simian varicella virus glycoprotein C, which is nonessential for in vitro replication.
    Gray WL; Byrne BH
    Arch Virol; 2003 Mar; 148(3):537-45. PubMed ID: 12607104
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
    He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
    J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Use of a Bacterial Artificial Chromosome to Generate Recombinant SARS-CoV-2 Expressing Robust Levels of Reporter Genes.
    Ye C; Martinez-Sobrido L
    Microbiol Spectr; 2022 Dec; 10(6):e0273222. PubMed ID: 36342302
    [TBL] [Abstract][Full Text] [Related]  

  • 92. SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA.
    Jack A; Ferro LS; Trnka MJ; Wehri E; Nadgir A; Nguyenla X; Fox D; Costa K; Stanley S; Schaletzky J; Yildiz A
    PLoS Biol; 2021 Oct; 19(10):e3001425. PubMed ID: 34634033
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Selection of viral variants during persistent infection of insectivorous bat cells with Middle East respiratory syndrome coronavirus.
    Banerjee A; Subudhi S; Rapin N; Lew J; Jain R; Falzarano D; Misra V
    Sci Rep; 2020 Apr; 10(1):7257. PubMed ID: 32350357
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies.
    Faber M; Lamirande EW; Roberts A; Rice AB; Koprowski H; Dietzschold B; Schnell MJ
    J Gen Virol; 2005 May; 86(Pt 5):1435-1440. PubMed ID: 15831955
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice.
    Mamedov T; Yuksel D; Ilgın M; Gurbuzaslan I; Gulec B; Yetiskin H; Uygut MA; Islam Pavel ST; Ozdarendeli A; Mammadova G; Say D; Hasanova G
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452461
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
    Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
    J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays.
    Sholukh AM; Fiore-Gartland A; Ford ES; Miner MD; Hou YJ; Tse LV; Kaiser H; Zhu H; Lu J; Madarampalli B; Park A; Lempp FA; St Germain R; Bossard EL; Kee JJ; Diem K; Stuart AB; Rupert PB; Brock C; Buerger M; Doll MK; Randhawa AK; Stamatatos L; Strong RK; McLaughlin C; Huang ML; Jerome KR; Baric RS; Montefiori D; Corey L
    J Clin Microbiol; 2021 Sep; 59(10):e0052721. PubMed ID: 34288726
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Ferristatin II Efficiently Inhibits SARS-CoV-2 Replication in Vero Cells.
    Sokolov A; Isakova-Sivak I; Grudinina N; Mezhenskaya D; Litasova E; Kostevich V; Stepanova E; Rak A; Sychev I; Kirik O; Rudenko L
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215911
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Identification of candidate gammaherpesvirus 68 genes required for virus replication by signature-tagged transposon mutagenesis.
    Moorman NJ; Lin CY; Speck SH
    J Virol; 2004 Oct; 78(19):10282-90. PubMed ID: 15367594
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
    Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
    J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.